Abbott Laboratories vs. Zentalis Pharmaceuticals, Inc. Common Stock
ABT
Abbott Laboratories
$99.60 +1.13%
VS ZNTLZentalis Pharmaceuticals, Inc. Common Stock
$2.60 -3.70%
Abbott Laboratories (ABT) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| ABT | ZNTL | |
|---|---|---|
| Market Cap | $172.35 billion | $255.61 million |
| Revenue (TTM) | — | — |
| Net Income (TTM) | — | $-139,545,000 |
ABT leads on 1 of 1 size & scale factors.
Valuation
| ABT | ZNTL | |
|---|---|---|
| Price / Book | — | 1.78 |
ABT and ZNTL split the valuation factors evenly.
Profitability
| ABT | ZNTL | |
|---|---|---|
| Return on Equity | — | -97.15% |
ABT and ZNTL split the profitability factors evenly.
Dividend
| ABT | ZNTL | |
|---|---|---|
| Dividend Yield | 2.53% | — |
ABT and ZNTL split the dividend factors evenly.
Risk & Sentiment
| ABT | ZNTL | |
|---|---|---|
| Short Interest | 0.57% | 0.64% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, ZNTL overview, ZNTL financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.